photo of Dr Marc Seal

Dr Marc Seal

Dr Marc Seal

Details

Role Group Leader / Snr Princ Research Fellow
Research area Clinical Sciences

Contact

Phone +61 3 9936 6678
Available for student supervision
Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support a two-year postdoctoral position in the Section of Neuroimaging, Institute of Psychiatry(IOP), Kings College London. Subsequently, Dr Seal was able to obtain a NARSAD Young Investigator Award (2003-2005) to continue his postdoctoral training in neuroimaging. In 2005 Dr Seal returned to Australia as a member of the Senior Research Group at The Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne. In this position he coordinated several large investigations measuring changes in brain structure and function across the life-span. On the basis of this work he was awarded the Ronald Phillip Griffith Fellowship (2007-2009). From 2007-2010 he successfully coordinated onsite Australia’s largest study investigating the neurocognitive impact of heavy cannabis use on brain development (NHMRC Project 459111).

In 2010 he was was appointed Group Leader of the Developmental Imaging research group at the Murdoch Children's Research Institute. In this role he is responsible for coordinating and facilitating research utilising the Research MRI Scanner and supervises a multidisciplinary team of clinicians, MRI technologists and neuroscientists. He is currently involved in several ongoing studies of neurodevelopment including as Chief Investigator on NHMRC Project Grants and ARC Discovery Grants. He holds a joint appointment (0.5) as a Principal Research Fellow in the Department of Paediatrics, The University of Melbourne
Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support...
Dr Seal trained as a clinical neuropsychologist and has over 15 years experience in coordinating neuroimaging investigations of brain development. After completing his PhD he was awarded a Wellcome Trust International Fellowship (2001-2002) to support a two-year postdoctoral position in the Section of Neuroimaging, Institute of Psychiatry(IOP), Kings College London. Subsequently, Dr Seal was able to obtain a NARSAD Young Investigator Award (2003-2005) to continue his postdoctoral training in neuroimaging. In 2005 Dr Seal returned to Australia as a member of the Senior Research Group at The Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne. In this position he coordinated several large investigations measuring changes in brain structure and function across the life-span. On the basis of this work he was awarded the Ronald Phillip Griffith Fellowship (2007-2009). From 2007-2010 he successfully coordinated onsite Australia’s largest study investigating the neurocognitive impact of heavy cannabis use on brain development (NHMRC Project 459111).

In 2010 he was was appointed Group Leader of the Developmental Imaging research group at the Murdoch Children's Research Institute. In this role he is responsible for coordinating and facilitating research utilising the Research MRI Scanner and supervises a multidisciplinary team of clinicians, MRI technologists and neuroscientists. He is currently involved in several ongoing studies of neurodevelopment including as Chief Investigator on NHMRC Project Grants and ARC Discovery Grants. He holds a joint appointment (0.5) as a Principal Research Fellow in the Department of Paediatrics, The University of Melbourne

Top Publications

  • Geraghty, DAP, Anderson, V, Bray, K, Hearps, SJC, Fabiano, F, Babl, FE, Davis, GA, Parkin, GM, Rausa, VC, Anderson, N, et al. Longitudinal neurocognitive trajectories and risk factors in the first three months following pediatric concussion.. Brain Inj 1 -9 2024
    view publication
  • Swaney, EEK, Babl, FE, Rausa, VC, Anderson, N, Hearps, SJC, Parkin, G, Hart-Smith, G, Zaw, T, Carroll, L, Takagi, M, et al. Discovery of Alpha-1-Antichymotrypsin as a Marker of Delayed Recovery from Concussion in Children.. J Neurotrauma 2024
    view publication
  • Pozzi, E, Rakesh, D, Gracia-Tabuenca, Z, Bray, KO, Richmond, S, Seal, ML, Schwartz, O, Vijayakumar, N, Yap, MBH, Whittle, S. Investigating Associations Between Maternal Behavior and the Development of Functional Connectivity During the Transition From Late Childhood to Early Adolescence.. Biol Psychiatry Cogn Neurosci Neuroimaging 9(4) : 398 -406 2024
    view publication
  • Adamson, CL, Alexander, B, Kelly, CE, Ball, G, Beare, R, Cheong, JLY, Spittle, AJ, Doyle, LW, Anderson, PJ, Seal, ML, et al. Updates to the Melbourne Children's Regional Infant Brain Software Package (M-CRIB-S).. Neuroinformatics 22(2) : 207 -223 2024
    view publication
  • Fan, F, Babl, FE, Swaney, EEK, Hearps, SJC, Takagi, M, Emery-Corbin, SJ, Dagley, LF, Yousef, J, Parkin, GM, Rausa, VC, et al. Capillary blood protein markers of posttraumatic headache in children after concussion.. J Neurosurg Pediatr 1 -9 2024
    view publication

Page 1 of 43

Career information